Quality of life after haematopoietic stem cell transplantation in a multiracial population

Document Type

Article

Publication Date

12-1-2011

Abstract

Haematopoietic stem cell transplantation (HSCT) was started in Malaysia since 1993 and it has improved the survival of patients with otherwise fatal haematological diseases. This study was initiated because quality of life of these survivors is an important tool in assessing the outcome of this treatment modality. The secondary objective was to identify factors that influenced their quality of life. The European Organization of Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-30) was used to assess the quality of life of eligible patients. A total of 62 patents were recruited. The mean global health score (QoL) was 71.2. The major symptoms faced by our patients were fatigue, financial difficulty and appetite loss. Appetite loss was an independent adverse factor for lower QoL.

Keywords

Quality of life, Haematopoietic stem cell transplantation, EORTC-30, Appetite loss

Divisions

fac_med

Publication Title

Medical Journal of Malaysia

Volume

66

Issue

5

Publisher

Malaysian Medical Association

This document is currently not available here.

Share

COinS